![Alexandra Kropotova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 155 866 $ am 31.05.2026
Alexandra Kropotova is currently an Independent Director at iBio, Inc. since 2020 and Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Formerly, Dr. Kropotova worked at Pfizer Inc. from 2002 to 2007 as Director & Head-Global Clinical Respiratory, at Sanofi from 2007 to 2016 as Vice President-Strategy & Head-Strategic Planning, and at Teva Pharmaceuticals, Inc. from 2016 to 2022 as VP-Global Specialty Research & Development.
Education includes an MBA from Ohio University Graduate College and a doctorate from Pacific State Medical University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.03.2026 | 43 296 ( 0,06 % ) | 155 866 $ | 31.05.2026 | |
IBIO, INC. -.--% | 20.11.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IBIO, INC. | Direktor/Vorstandsmitglied | 14.10.2020 |
| SAB BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Teva Pharmaceuticals, Inc.
 Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.06.2022 |
| SANOFI | Corporate Officer/Principal | 01.01.2016 |
| PFIZER INC. | Direktor/Vorstandsmitglied | 01.01.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
 Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
